Search Results - Tim Welliver
- Showing 1 - 1 results of 1
-
1
433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04 by Bhumsuk Keam, Kevin Harrington, Ezra Cohen, Jean-Pascal Machiels, Feng Jin, Alison Forgie, Shanhong Guan, Jaume Pons, Beatriz Cirauqui, Sjoukje Oosting, Tim Welliver, Philip Fanning, Katherine Ruffner, Sophia Randolph
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article